Increasing use of NOAC and antiplatelet combination therapy in atrial fibrillation following myocardial infarction or percutaneous coronary intervention

C. Sindet-Pedersen, L. Staerk, M. Lamberts, J. S. Berger, A. Nissen Bonde, J. Langtved Pallisgaard, Christian Torp-Pedersen, G. Gislason, J. Bjerring Olesen

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article number2876
JournalEuropean Heart Journal
Volume38
Issue numberSuppl. 1
Pages (from-to)616
ISSN0195-668X
DOIs
Publication statusPublished - 2017
EventESC Congress, European Society of Cardiology - Barcelona, Spain
Duration: 26 Aug 201730 Aug 2017

Conference

ConferenceESC Congress, European Society of Cardiology
CountrySpain
CityBarcelona
Period26/08/201730/08/2017

Cite this

Sindet-Pedersen, C., Staerk, L., Lamberts, M., Berger, J. S., Bonde, A. N., Pallisgaard, J. L., Torp-Pedersen, C., Gislason, G., & Olesen, J. B. (2017). Increasing use of NOAC and antiplatelet combination therapy in atrial fibrillation following myocardial infarction or percutaneous coronary intervention. European Heart Journal, 38(Suppl. 1), 616. [2876]. https://doi.org/10.1093/eurheartj/ehx504.2876